By applying polymerase chain reaction (PCR) test for Covid-19 to preeclampsia patients who applied to our hospital during the Covid-19 pandemic period, we investigated the frequency of Covid-19 related preeclampsia-like syndrome in this patient group.

The investigators studied the frequency of Covid-19 related preeclampsia-like syndrome by PCR test and lung ultrasound for Covid-19 to preeclampsia patients presenting to the instutution during the Covid-19 pandemic period. The first consecutive 100 preeclampsia patients presented to our hospital during the pandemic will be involved in our study. The primary outcome measure is to detect Covid-19 positivity among the preeclamptic pregnant women..

Inclusion Criteria:

• First consecutive 100 pregnant women presenting with preeclamptic symptoms and signs between March 15, 2020 and June 1, 2020.

Exclusion Criteria:

• The pregnancies with known diagnosis of preeclampsia before Covid-19 pandemic
• Preeclamptic patient without a Covid-19 PCR test result
• Pregnant women who does not want to participate in study or does not want their personal informations to be shared
• Pregnant women less than 18 years old and more than 40 years old are excluded

Pregnant females are studied.

First consecutive 100 preeclamptic pregnant women applied to our hospital during covid-19 pandemic

demographic data of the participants and diagnostic test results will be shared